Peptic ulcers develop in the stomach and upper small intestine. Common symptoms include abdominal pain. The document discusses the causes, risk factors, diagnosis, and treatment of peptic ulcers. Key points are that Helicobacter pylori infection and NSAID use are leading causes, and treatment involves eradicating H. pylori if present, reducing NSAID use, and using medications to reduce acid production and promote healing.
ANTIULCER DRUGS and RECENT ADVANCES.pptxSMRITI920472
This document discusses antiulcer drugs and summarizes their mechanisms and uses. Peptic ulcers result from an imbalance between aggressive factors like gastric acid and defensive factors like mucus. Common causes include H. pylori bacteria, NSAIDs, smoking, and stress. Major classes of antiulcer drugs are H2 antagonists, proton pump inhibitors, antacids, and ulcer protective drugs. H2 antagonists and proton pump inhibitors suppress acid production. Antacids neutralize gastric acid. Sucralfate and bismuth subcitrate coat ulcers and promote healing. Combinations of antibiotics are used to treat H. pylori infections associated with ulcers.
Irritable bowel syndrome is a common condition affecting the digestive system.
Symptoms of irritable bowel syndrome include stomach cramps, bloating, diarrhoea and constipation. These may come and go over time.
Making changes to your diet and lifestyle, like avoiding things that trigger your symptoms, can help ease irritable bowel syndrome.
Irritable bowel syndrome - diagnosis, pathophysiology and pharmacologySIVASWAROOP YARASI
irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhoea or constipation, or both. IBS is a chronic condition that you'll need to manage long term.
This document provides an overview of peptic ulcer disease. It defines peptic ulcers as painful open sores or ulcers in the lining of the esophagus, stomach, or duodenum, which are most often caused by infection with Helicobacter pylori bacteria. The document discusses the etiology, risk factors, signs and symptoms, complications, diagnosis, and treatment of peptic ulcers. Treatment options include antibiotics to treat H. pylori infections, acid blockers to reduce stomach acid production, antacids to neutralize acid, and lifestyle modifications to avoid exacerbating factors. Hospitalization may be required for severe, unresponsive cases or if complications like hemorrhaging occur.
Helicobacter pylori and Peptic Ulcer diseaseDiaa Srahin
Case Study
Clinical Case Summary
History
Helicobacter pylori
Biochemical characteristics
Transmission
Epidemiology
Global incidence of H. pylori infection
risk factors for acquisition of H.pylori
Immune responses
Pathogenesis
Helicobacter pylori Virulence Factors
Clinical Presentation
Complications
Peptic Ulcer
Diagnosis
Treatment
Prevention
Constipation is the symptom and is associated with primary & Secondary causes. Constipation is defined as occurrence of >3 episodes of bowel movements. the Rome III criteria defines the objective classification and bristol stool chart helps in assessing the type of stools passed. Management of constipation deals with early assess, treating the cause, adjuvant management, Pharmacological Management (laxatives, suppositories & enemas) and following constipation prevention bundle.
This document discusses the role of beta blockers in the treatment of hypertension. It covers the pharmacodynamics and pharmacokinetics of beta blockers, specific agents used, their adverse effects, history of use, and concerns regarding their use. While beta blockers were previously considered first-line treatment for hypertension, more recent trials have shown other agents may provide better outcomes. However, beta blockers are still important treatment options, especially newer vasodilating agents like nebivolol and carvedilol which have shown benefits over older non-vasodilating beta blockers.
Peptic ulcers develop in the stomach and upper small intestine. Common symptoms include abdominal pain. The document discusses the causes, risk factors, diagnosis, and treatment of peptic ulcers. Key points are that Helicobacter pylori infection and NSAID use are leading causes, and treatment involves eradicating H. pylori if present, reducing NSAID use, and using medications to reduce acid production and promote healing.
ANTIULCER DRUGS and RECENT ADVANCES.pptxSMRITI920472
This document discusses antiulcer drugs and summarizes their mechanisms and uses. Peptic ulcers result from an imbalance between aggressive factors like gastric acid and defensive factors like mucus. Common causes include H. pylori bacteria, NSAIDs, smoking, and stress. Major classes of antiulcer drugs are H2 antagonists, proton pump inhibitors, antacids, and ulcer protective drugs. H2 antagonists and proton pump inhibitors suppress acid production. Antacids neutralize gastric acid. Sucralfate and bismuth subcitrate coat ulcers and promote healing. Combinations of antibiotics are used to treat H. pylori infections associated with ulcers.
Irritable bowel syndrome is a common condition affecting the digestive system.
Symptoms of irritable bowel syndrome include stomach cramps, bloating, diarrhoea and constipation. These may come and go over time.
Making changes to your diet and lifestyle, like avoiding things that trigger your symptoms, can help ease irritable bowel syndrome.
Irritable bowel syndrome - diagnosis, pathophysiology and pharmacologySIVASWAROOP YARASI
irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhoea or constipation, or both. IBS is a chronic condition that you'll need to manage long term.
This document provides an overview of peptic ulcer disease. It defines peptic ulcers as painful open sores or ulcers in the lining of the esophagus, stomach, or duodenum, which are most often caused by infection with Helicobacter pylori bacteria. The document discusses the etiology, risk factors, signs and symptoms, complications, diagnosis, and treatment of peptic ulcers. Treatment options include antibiotics to treat H. pylori infections, acid blockers to reduce stomach acid production, antacids to neutralize acid, and lifestyle modifications to avoid exacerbating factors. Hospitalization may be required for severe, unresponsive cases or if complications like hemorrhaging occur.
Helicobacter pylori and Peptic Ulcer diseaseDiaa Srahin
Case Study
Clinical Case Summary
History
Helicobacter pylori
Biochemical characteristics
Transmission
Epidemiology
Global incidence of H. pylori infection
risk factors for acquisition of H.pylori
Immune responses
Pathogenesis
Helicobacter pylori Virulence Factors
Clinical Presentation
Complications
Peptic Ulcer
Diagnosis
Treatment
Prevention
Constipation is the symptom and is associated with primary & Secondary causes. Constipation is defined as occurrence of >3 episodes of bowel movements. the Rome III criteria defines the objective classification and bristol stool chart helps in assessing the type of stools passed. Management of constipation deals with early assess, treating the cause, adjuvant management, Pharmacological Management (laxatives, suppositories & enemas) and following constipation prevention bundle.
This document discusses the role of beta blockers in the treatment of hypertension. It covers the pharmacodynamics and pharmacokinetics of beta blockers, specific agents used, their adverse effects, history of use, and concerns regarding their use. While beta blockers were previously considered first-line treatment for hypertension, more recent trials have shown other agents may provide better outcomes. However, beta blockers are still important treatment options, especially newer vasodilating agents like nebivolol and carvedilol which have shown benefits over older non-vasodilating beta blockers.
Irritable bowel syndrome (IBS) is characterized by chronic abdominal pain or discomfort associated with changes in bowel habits. Common symptoms include abdominal discomfort relieved with defecation, changes in stool frequency or form. Treatment depends on whether constipation or diarrhea predominates, and may include increased fiber, bulk forming laxatives, antispasmodics, or anti-inflammatory drugs. While the cause is unknown, theories include altered stress responses, low-grade inflammation, and changes in gut microbiota. Diet modifications and lifestyle changes can help manage symptoms.
Peptic ulcers form in the stomach or duodenum due to an imbalance between acid secretions and mucosal defenses. Risk factors include H. pylori infection in 90% of cases, NSAID use, and stress. Complications include hemorrhage, perforation, and obstruction. H. pylori survives stomach acid through urease production. Diagnosis involves symptoms and imaging. Treatment depends on complications but usually involves antibiotics to eradicate H. pylori along with acid suppression. Surgery may be needed for perforation or obstruction.
The document discusses anti-ulcer drugs. It begins by describing peptic ulcers and the imbalance between aggressive and defensive factors that can lead to their development. It then covers the classes of anti-ulcer drugs, including H2 blockers that reduce acid secretion, proton pump inhibitors, prostaglandin analogs, and antacids. Sucralfate and colloidal bismuth subcitrate are also covered as ulcer protective drugs. Diagnostic tests for ulcers like endoscopy and barium meal are mentioned. The goal of anti-ulcer treatment is outlined as relieving pain, promoting healing, preventing complications, and reducing relapse.
Dyspepsia refers to any symptoms thought to originate from the upper gastrointestinal tract. There are several potential mechanisms that can cause dyspepsia, including gastroesophageal acid reflux, gastric motor dysfunction, and visceral afferent hypersensitivity. Gastroesophageal acid reflux can be caused by reduced lower esophageal sphincter tone, frequent transient lower esophageal sphincter relaxations, overeating, aerophagia, impaired esophageal body motility, reduced salivary secretion, and hiatal hernias. Gastric motor dysfunction may involve delayed gastric emptying or impaired gastric fundus relaxation after eating. Visceral afferent hypersensitivity is proposed to disturb gastric sensory function in functional
This document discusses peptic ulcers, including their definition, types, causes, signs and symptoms, diagnosis, pathogenesis, differential diagnosis, allopathic management, and holistic management approaches like diet therapy, acupuncture, hydrotherapy, chromotherapy, massage therapy, herbal remedies, and yoga therapy. The holistic approaches aim to promote healing and repair of damaged tissue through strategies like probiotics, antioxidants, dietary polyphenols, and protective foods.
This document provides information on bronchial asthma including its definition, triggers, pathophysiology, classification, airway inflammation, and treatment options. Bronchial asthma is characterized by reversible airway obstruction due to hyperresponsiveness of the tracheobronchial smooth muscles. Common triggers include allergens, infections, exercise, and environmental factors. Treatment includes bronchodilators like beta-2 agonists, methylxanthines, anticholinergics, mast cell stabilizers, leukotriene antagonists, and corticosteroids.
The document discusses peptic ulcers, including:
1. It provides an introduction defining peptic ulcers and their locations in the stomach or duodenum.
2. It discusses the history of discoveries around Helicobacter pylori being identified as a primary cause of peptic ulcers in the 1980s.
3. It describes common symptoms of peptic ulcers such as abdominal pain that is often relieved by food for duodenal ulcers but worsened by food for gastric ulcers.
This document provides an overview of peptic ulcer disease. It begins with definitions of acid peptic disease and what constitutes a peptic ulcer. It then discusses the epidemiology of peptic ulcers and covers the etiology and pathophysiology, including factors that damage the stomach lining like excess acid secretion, NSAIDs, and Helicobacter pylori infection. The document reviews the history of drug development for peptic ulcers and describes various drug classes used for treatment, including antacids, H2 receptor antagonists, and proton pump inhibitors. It also discusses testing and treatment for H. pylori infection, as well as principles of medical management of peptic ulcers.
Antitussive and expectorents, respiratory stimulationMANEESHA KUSHWAHA
This document discusses antitussives, expectorants, and respiratory stimulants. It defines these categories of drugs and provides examples of common medications in each category. Antitussives suppress coughing, possibly by reducing brain cough center activity. Expectorants promote removal of respiratory secretions. Mucolytics liquefy mucus while pharyngeal demulcents soothe the throat. Codeine is a commonly used antitussive that raises the cough stimulus threshold. Guaifenesin is a direct-acting expectorant that increases sputum volume and fluidity. Doxapram is a respiratory stimulant used to treat respiratory depression and failure by stimulating peripheral chemoreceptors and the brainstem.
- IBS is a functional disorder of the colon that causes abdominal pain, bloating, and changes in bowel habits like diarrhea and constipation. It is more common in women and is diagnosed based on symptoms.
- The colon's contractions can be abnormal in IBS, affecting how contents move through the colon. Common causes include changes in the nervous system, diet, stress, and imbalances in neurotransmitters like serotonin.
- Symptoms include abdominal pain or discomfort and changes in bowel movements. Treatment focuses on lifestyle changes, medications to relieve symptoms, probiotics, and stress management. IBS does not lead to other diseases or harm the intestines.
This document discusses anti-ulcer drugs. It states that peptic ulcers are caused by hydrochloric acid destroying the stomach lining, infection with H. pylori bacteria, or long term NSAID use. The goals of anti-ulcer treatment are to relieve pain, accelerate healing, and prevent recurrence. Treatment approaches include reducing acid with antacids or acid production inhibitors, strengthening the mucosal barrier with protective drugs, and eradicating H. pylori infections. Common anti-ulcer drugs fall into categories of acid neutralizers, acid production inhibitors, mucosal protective agents, and antibiotics used in combination with acid reducers to eradicate H. pylori.
Type 2 dm gdm new updates & guidelinesSachin Verma
Type 2 diabetes is a multifactorial disorder characterised by progressive pancreatic beta-cell dysfunction and insulin- resistance, leading to relative insulin deficiency, chronic hyperglycaemia, and various complications.
The treatment options for this disorder, which aim at correcting one or other of the two major pathophysiological mechanisms, have been hamstrung by unacceptable side-effects, lack of patient acceptability, and loss of efficacy over time.
1) Inflammatory bowel disease (IBD) refers to chronic inflammation of the digestive tract and includes both Crohn's disease and ulcerative colitis.
2) IBD may result from a failure of regulatory lymphocytes and cytokines to control inflammation, and non-pathogenic bowel flora is also thought to play a role.
3) Ulcerative colitis causes inflammation of the colon and sigmoid colon, while Crohn's disease causes patchy inflammation that can affect any part of the digestive tract from mouth to anus.
GERD (gastro esophageal reflux disease) and Achalasia cardiaRishabh Handa
This document discusses gastroesophageal reflux disease (GERD) and achalasia cardia. It defines GERD as a chronic disorder related to backflow of gastric contents into the esophagus, causing symptoms. It describes typical GERD symptoms like heartburn and regurgitation. It also discusses atypical symptoms and evaluates the pathophysiology of GERD, focusing on the lower esophageal sphincter, esophageal peristalsis, crural diaphragm, and stomach function. Finally, it outlines various tests used to assess GERD, including endoscopy, manometry, and pH monitoring.
The document discusses respiratory diseases and their pharmacotherapy. It begins with an overview of the anatomy and physiology of the human respiratory system. It then discusses some major respiratory diseases - asthma and chronic obstructive pulmonary disease (COPD). For asthma, it covers symptoms, causes, pathophysiology, diagnosis, and pharmacological treatments including bronchodilators, glucocorticoids, leukotriene inhibitors, anti-IgE antibody, and mast cell stabilizers. For COPD, it discusses symptoms, causes, pathophysiology, diagnosis, and pharmacological therapies as well as non-pharmacological treatments.
Prokinetics are the type of drugs which enhances gastrointestinal motility/transit by
increasing the frequency or strength of contractions.
They speed up gastric emptying by enhancing coordinated propulsive motility.
Treat Gastrointestinal symptoms : Abdominal discomfort, Bloating, constipation,
Heart burn, nausea and vomiting. And few gastrointestinal disorders : irritable bowel
Syndrome, gastritis, gastroparesis and functional dyspepsia.
Increases gastric emptying
Relief of gastric stasis
Decreases reflux esophagitis/heart burn
Decreases regurgitation of gastric contents& emesis
Peptic ulcers are sores that develop in the lining of the stomach, lower esophagus, or small intestine. They're usually formed as a result of inflammation caused by the bacteria H. pylori, as well as from erosion from stomach acids. Peptic ulcers are a fairly common health problem.
This document provides information on peptic ulcer disease, including its prevalence, risk factors, types, clinical manifestations, diagnosis, medical and surgical management, complications, nursing care, and follow up. Some key points:
- Peptic ulcers affect 4-10 per 1000 people in India and are more common in males aged 30-60. Risk factors include H. pylori infection, smoking, alcohol, NSAIDs.
- Types include acute, chronic, gastric, and duodenal ulcers. Chronic ulcers erode through the stomach/duodenal wall.
- Symptoms include abdominal pain relieved by food. Tests include endoscopy, biopsy to detect H. pylori.
- Treatment
Irritable bowel syndrome (IBS) is characterized by chronic abdominal pain or discomfort associated with changes in bowel habits. Common symptoms include abdominal discomfort relieved with defecation, changes in stool frequency or form. Treatment depends on whether constipation or diarrhea predominates, and may include increased fiber, bulk forming laxatives, antispasmodics, or anti-inflammatory drugs. While the cause is unknown, theories include altered stress responses, low-grade inflammation, and changes in gut microbiota. Diet modifications and lifestyle changes can help manage symptoms.
Peptic ulcers form in the stomach or duodenum due to an imbalance between acid secretions and mucosal defenses. Risk factors include H. pylori infection in 90% of cases, NSAID use, and stress. Complications include hemorrhage, perforation, and obstruction. H. pylori survives stomach acid through urease production. Diagnosis involves symptoms and imaging. Treatment depends on complications but usually involves antibiotics to eradicate H. pylori along with acid suppression. Surgery may be needed for perforation or obstruction.
The document discusses anti-ulcer drugs. It begins by describing peptic ulcers and the imbalance between aggressive and defensive factors that can lead to their development. It then covers the classes of anti-ulcer drugs, including H2 blockers that reduce acid secretion, proton pump inhibitors, prostaglandin analogs, and antacids. Sucralfate and colloidal bismuth subcitrate are also covered as ulcer protective drugs. Diagnostic tests for ulcers like endoscopy and barium meal are mentioned. The goal of anti-ulcer treatment is outlined as relieving pain, promoting healing, preventing complications, and reducing relapse.
Dyspepsia refers to any symptoms thought to originate from the upper gastrointestinal tract. There are several potential mechanisms that can cause dyspepsia, including gastroesophageal acid reflux, gastric motor dysfunction, and visceral afferent hypersensitivity. Gastroesophageal acid reflux can be caused by reduced lower esophageal sphincter tone, frequent transient lower esophageal sphincter relaxations, overeating, aerophagia, impaired esophageal body motility, reduced salivary secretion, and hiatal hernias. Gastric motor dysfunction may involve delayed gastric emptying or impaired gastric fundus relaxation after eating. Visceral afferent hypersensitivity is proposed to disturb gastric sensory function in functional
This document discusses peptic ulcers, including their definition, types, causes, signs and symptoms, diagnosis, pathogenesis, differential diagnosis, allopathic management, and holistic management approaches like diet therapy, acupuncture, hydrotherapy, chromotherapy, massage therapy, herbal remedies, and yoga therapy. The holistic approaches aim to promote healing and repair of damaged tissue through strategies like probiotics, antioxidants, dietary polyphenols, and protective foods.
This document provides information on bronchial asthma including its definition, triggers, pathophysiology, classification, airway inflammation, and treatment options. Bronchial asthma is characterized by reversible airway obstruction due to hyperresponsiveness of the tracheobronchial smooth muscles. Common triggers include allergens, infections, exercise, and environmental factors. Treatment includes bronchodilators like beta-2 agonists, methylxanthines, anticholinergics, mast cell stabilizers, leukotriene antagonists, and corticosteroids.
The document discusses peptic ulcers, including:
1. It provides an introduction defining peptic ulcers and their locations in the stomach or duodenum.
2. It discusses the history of discoveries around Helicobacter pylori being identified as a primary cause of peptic ulcers in the 1980s.
3. It describes common symptoms of peptic ulcers such as abdominal pain that is often relieved by food for duodenal ulcers but worsened by food for gastric ulcers.
This document provides an overview of peptic ulcer disease. It begins with definitions of acid peptic disease and what constitutes a peptic ulcer. It then discusses the epidemiology of peptic ulcers and covers the etiology and pathophysiology, including factors that damage the stomach lining like excess acid secretion, NSAIDs, and Helicobacter pylori infection. The document reviews the history of drug development for peptic ulcers and describes various drug classes used for treatment, including antacids, H2 receptor antagonists, and proton pump inhibitors. It also discusses testing and treatment for H. pylori infection, as well as principles of medical management of peptic ulcers.
Antitussive and expectorents, respiratory stimulationMANEESHA KUSHWAHA
This document discusses antitussives, expectorants, and respiratory stimulants. It defines these categories of drugs and provides examples of common medications in each category. Antitussives suppress coughing, possibly by reducing brain cough center activity. Expectorants promote removal of respiratory secretions. Mucolytics liquefy mucus while pharyngeal demulcents soothe the throat. Codeine is a commonly used antitussive that raises the cough stimulus threshold. Guaifenesin is a direct-acting expectorant that increases sputum volume and fluidity. Doxapram is a respiratory stimulant used to treat respiratory depression and failure by stimulating peripheral chemoreceptors and the brainstem.
- IBS is a functional disorder of the colon that causes abdominal pain, bloating, and changes in bowel habits like diarrhea and constipation. It is more common in women and is diagnosed based on symptoms.
- The colon's contractions can be abnormal in IBS, affecting how contents move through the colon. Common causes include changes in the nervous system, diet, stress, and imbalances in neurotransmitters like serotonin.
- Symptoms include abdominal pain or discomfort and changes in bowel movements. Treatment focuses on lifestyle changes, medications to relieve symptoms, probiotics, and stress management. IBS does not lead to other diseases or harm the intestines.
This document discusses anti-ulcer drugs. It states that peptic ulcers are caused by hydrochloric acid destroying the stomach lining, infection with H. pylori bacteria, or long term NSAID use. The goals of anti-ulcer treatment are to relieve pain, accelerate healing, and prevent recurrence. Treatment approaches include reducing acid with antacids or acid production inhibitors, strengthening the mucosal barrier with protective drugs, and eradicating H. pylori infections. Common anti-ulcer drugs fall into categories of acid neutralizers, acid production inhibitors, mucosal protective agents, and antibiotics used in combination with acid reducers to eradicate H. pylori.
Type 2 dm gdm new updates & guidelinesSachin Verma
Type 2 diabetes is a multifactorial disorder characterised by progressive pancreatic beta-cell dysfunction and insulin- resistance, leading to relative insulin deficiency, chronic hyperglycaemia, and various complications.
The treatment options for this disorder, which aim at correcting one or other of the two major pathophysiological mechanisms, have been hamstrung by unacceptable side-effects, lack of patient acceptability, and loss of efficacy over time.
1) Inflammatory bowel disease (IBD) refers to chronic inflammation of the digestive tract and includes both Crohn's disease and ulcerative colitis.
2) IBD may result from a failure of regulatory lymphocytes and cytokines to control inflammation, and non-pathogenic bowel flora is also thought to play a role.
3) Ulcerative colitis causes inflammation of the colon and sigmoid colon, while Crohn's disease causes patchy inflammation that can affect any part of the digestive tract from mouth to anus.
GERD (gastro esophageal reflux disease) and Achalasia cardiaRishabh Handa
This document discusses gastroesophageal reflux disease (GERD) and achalasia cardia. It defines GERD as a chronic disorder related to backflow of gastric contents into the esophagus, causing symptoms. It describes typical GERD symptoms like heartburn and regurgitation. It also discusses atypical symptoms and evaluates the pathophysiology of GERD, focusing on the lower esophageal sphincter, esophageal peristalsis, crural diaphragm, and stomach function. Finally, it outlines various tests used to assess GERD, including endoscopy, manometry, and pH monitoring.
The document discusses respiratory diseases and their pharmacotherapy. It begins with an overview of the anatomy and physiology of the human respiratory system. It then discusses some major respiratory diseases - asthma and chronic obstructive pulmonary disease (COPD). For asthma, it covers symptoms, causes, pathophysiology, diagnosis, and pharmacological treatments including bronchodilators, glucocorticoids, leukotriene inhibitors, anti-IgE antibody, and mast cell stabilizers. For COPD, it discusses symptoms, causes, pathophysiology, diagnosis, and pharmacological therapies as well as non-pharmacological treatments.
Prokinetics are the type of drugs which enhances gastrointestinal motility/transit by
increasing the frequency or strength of contractions.
They speed up gastric emptying by enhancing coordinated propulsive motility.
Treat Gastrointestinal symptoms : Abdominal discomfort, Bloating, constipation,
Heart burn, nausea and vomiting. And few gastrointestinal disorders : irritable bowel
Syndrome, gastritis, gastroparesis and functional dyspepsia.
Increases gastric emptying
Relief of gastric stasis
Decreases reflux esophagitis/heart burn
Decreases regurgitation of gastric contents& emesis
Peptic ulcers are sores that develop in the lining of the stomach, lower esophagus, or small intestine. They're usually formed as a result of inflammation caused by the bacteria H. pylori, as well as from erosion from stomach acids. Peptic ulcers are a fairly common health problem.
This document provides information on peptic ulcer disease, including its prevalence, risk factors, types, clinical manifestations, diagnosis, medical and surgical management, complications, nursing care, and follow up. Some key points:
- Peptic ulcers affect 4-10 per 1000 people in India and are more common in males aged 30-60. Risk factors include H. pylori infection, smoking, alcohol, NSAIDs.
- Types include acute, chronic, gastric, and duodenal ulcers. Chronic ulcers erode through the stomach/duodenal wall.
- Symptoms include abdominal pain relieved by food. Tests include endoscopy, biopsy to detect H. pylori.
- Treatment
The document discusses peptic ulcers, including definitions, types, causes, risk factors, pathophysiology, clinical manifestations, diagnosis, management, and nursing considerations. Peptic ulcers are erosions in the GI tract caused by gastric acid and pepsin. There are three main types based on location: gastric, duodenal, and esophageal. Key risk factors include H. pylori infection, smoking, NSAIDs, and stress. Treatment involves reducing acid production, eradicating H. pylori if present, and surgery for severe cases. Nursing focuses on pain management, nutrition, risk reduction, and ensuring proper treatment adherence.
Peptic ulcer disease refers to open sores or ulcers in the lining of the stomach or duodenum caused by erosion of the protective mucosal barrier from gastric acid and enzymes. Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use are leading causes of peptic ulcers. Symptoms include dyspepsia, abdominal pain, and nausea. Endoscopy allows direct visualization of ulcers while biopsies detect H. pylori. Treatment involves proton pump inhibitors, antibiotics to eradicate H. pylori infections, and antacids.
Peptic ulcers develop in the stomach, esophagus, or duodenum (upper small intestine) and are usually caused by H. pylori bacteria or nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin. Symptoms include abdominal pain, nausea, vomiting, weight loss, and bloody stools. Diagnosis involves blood tests, breath tests, stool tests, endoscopy, or imaging. Treatment involves antibiotics to kill H. pylori, proton pump inhibitors to reduce acid, and medications to protect the stomach lining. Complications can include bleeding, perforation, and scarring.
peptic ulcer advance concepts of nursing.pptxajadoon84
The document discusses peptic ulcer disease including its definition, causes, symptoms, diagnostic testing, treatment, and nursing management. Peptic ulcers develop in the stomach, duodenum, or esophagus due to an imbalance between gastric acid and mucosal resistance. Common causes include H. pylori infection, NSAID use, and excess acid secretion. Symptoms include abdominal pain relieved by food or antacids as well as potential complications like bleeding. Treatment involves eradicating H. pylori, reducing acid production, and educating patients on lifestyle modifications.
The document discusses diseases of the stomach, including stomach ulcers and dyspepsia. It provides details on the causes of stomach ulcers such as Helicobacter pylori bacteria and NSAIDs. Symptoms, complications, diagnosis and treatment are described for stomach ulcers. Dyspepsia is defined as indigestion and its common causes include diet, lifestyle factors, and underlying diseases. Treatment focuses on eliminating H. pylori infections, reducing stomach acid production, and managing symptoms.
Benigne diseases of stomach are one of the serious conditions of our world.... so here u get littlebit information about these diseases...hope it will help you for your future study about these diseases... thank you.
H. pylori infection is the leading cause of peptic ulcer disease. Optimal treatment involves 14 days of multidrug therapy with antibiotics and acid suppressants to eradicate H. pylori and reduce risk of recurrence. Initial evaluation with endoscopy is recommended to diagnose and assess patients with alarm symptoms or those failing treatment. Lifestyle modifications like smoking cessation, limited alcohol and stress reduction also help prevent peptic ulcers.
Peptic ulcer ( a medical study)- definition, causes, pathophysiology etc martinshaji
Peptic ulcers include:
Gastric ulcers that occur on the inside of the stomach
Esophageal ulcers that occur inside the hollow tube (esophagus) that carries food from your throat to your stomach
Duodenal ulcers that occur on the inside of the upper portion of your small intestine (duodenum)
It's a myth that spicy foods or a stressful job can cause peptic ulcers. Doctors now know that a bacterial infection or some medications — not stress or diet — cause most peptic ulcers.
this is a detailed study on peptic ulcer
please comment
thank you
Peptic ulcer disease is primarily caused by an imbalance between aggressive factors, such as stomach acid and digestive enzymes, and protective factors, such as mucus production and blood flow to the gastrointestinal lining.
Peptic ulcer disease refers to lesions in the stomach or duodenum caused by an imbalance between protective and corrosive factors. Common types include gastric and duodenal ulcers. H. pylori infection is present in most ulcers and its eradication can cure ulcers and reduce recurrence. Treatment involves relieving symptoms, promoting healing, and preventing complications through lifestyle modifications, medications like PPIs, H2 blockers, and antibiotics targeted against H. pylori.
This document provides information about peptic ulcers, including their causes, symptoms, diagnosis, and treatment. Peptic ulcers develop as open sores in the stomach or small intestine due to excessive acid. The most common causes are infection by H. pylori bacteria and long-term use of pain medications like ibuprofen. Symptoms include stomach pain that is often relieved by food. Diagnosis involves tests to detect H. pylori and endoscopy. Treatment focuses on eliminating the bacteria with antibiotics if present, reducing acid production, and promoting healing. Lifestyle changes like hand washing can help prevent ulcers by reducing infection risk.
Helicobacter pylori infection causes about 19 out of 20 duodenal ulcers. H. pylori colonizes the stomach lining and causes chronic inflammation and damage through secreted toxins. Symptoms of duodenal ulcers include abdominal pain that is relieved by food or antacids. Diagnosis involves endoscopy or non-invasive breath and stool tests. Treatment consists of antibiotics to eradicate H. pylori combined with acid-reducing proton pump inhibitors or H2 blockers. Lifestyle changes and surgery for complications may also be used.
The document discusses peptic ulcer disease. It defines peptic ulcers as breaks in the stomach or duodenal lining that can be caused by an imbalance of factors like acid and pepsin production. About 70-90% of ulcers are associated with Helicobacter pylori bacteria. The document covers topics like anatomy, causes, symptoms, complications, diagnosis and treatment of peptic ulcers.
REFLUX DISEASE, GASTRITIS AND PEPTIC ULCER.pptxGowriLekshmi5
Gastroesophageal reflux disease, gastritis, and peptic ulcers are conditions that involve inflammation or damage to the lining of the esophagus, stomach or small intestine. GERD occurs when stomach acid leaks back up into the esophagus, potentially causing heartburn or damage. Gastritis is inflammation of the stomach lining that can be acute or chronic. Peptic ulcers develop as open sores in the stomach or duodenum. Common causes include H. pylori infection, long term NSAID use, and stomach acid. Symptoms vary but may include abdominal pain or discomfort. Treatment involves medications to reduce acid like PPIs, antibiotics to treat H. pylori if present
This document discusses conjunctivitis or pink eye. It defines conjunctivitis as swelling or inflammation of the conjunctiva, the thin layer lining the white part of the eye and inner eyelid. The document outlines that conjunctivitis can be viral, bacterial, or allergic in nature. Common signs and symptoms include redness, irritation, mild pain, swollen lids, blurred or reduced vision, burning eyes, tearing, and thick yellow discharge. Treatment typically involves medications like moxifloxacin, olopatadin, gatifloxacin, ofloxacin, gentamicin or ciprofloxacin.
This document provides an overview of pathophysiology of diabetes mellitus. It defines diabetes as a metabolic disease involving elevated blood glucose levels due to problems with insulin production or insulin resistance. The main types of diabetes are described as type 1, type 2, and gestational diabetes. Type 1 results from failure of insulin production and type 2 from insulin resistance. Signs and symptoms include increased thirst, frequent urination, weight loss and fatigue. Treatment involves lifestyle changes like diet and exercise as well as medications to improve insulin availability or overcome insulin resistance.
This document provides an overview of asthma pathophysiology. It defines asthma as a chronic inflammatory disease of the airways characterized by variable periodic symptoms, air flow obstruction, and bronchial hyperresponsiveness. It outlines the main types of asthma as occupational, drug-induced, allergic, and adult-onset. The etiology section notes that asthma causes are unclear but involve genetic and environmental factors like exposure to allergens. The document then lists headings for pathogenesis, signs and symptoms, complications, diagnosis, and plan of treatment but does not provide details on these topics.
Congestive heart failure occurs when the heart cannot pump enough blood to meet the body's needs. It can be caused by issues with the heart's structure, function, conduction or rhythm. Common symptoms include shortness of breath, swelling, fatigue, and insomnia. Diagnosis involves blood tests, chest x-rays, and tests of ejection fraction. Treatment includes medications like beta-blockers, ACE inhibitors, diuretics, and lifestyle changes like diet modification and exercise.
Iron deficiency anemia is caused by a lack of iron, which hinders the production of hemoglobin. It occurs most commonly due to blood loss, an insufficient iron diet, or an inability to absorb iron. The main symptoms are extreme fatigue, weakness, pale skin, and other symptoms related to insufficient oxygen transport. Treatment involves iron replacement therapy through oral or intravenous supplements.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
3. DEFINITION
A condition in which wounds appears in the lining of
stomach or duodenum , along with a burning stomach pain is
termed peptic ulcer.
Common causes include the bacteria H.Pylori and anti
inflammatory pain relievers including aspirin.
4. TYPES
Mainly it is of two types;
a. Gastric ulcer:- Affect the stomach lining and
characterized by pain while the food is still in stomach and
arises within a short period of time after food consumption.
b. Duodenal ulcer:- Affect the upper part of small
intestine and characterized by pain when stomach is empty or
after several hours of food consumption.
5. ETIOLOGY
NSAID’s drugs like Aspirin, Ibuprofen etc. used frequently
Smoking
Alcoholism
Stress
Spicy food
6. PATHOGENESIS
NSAID’s inhibits the secretion of prostaglandin actively
involved in blocking ulceration . In case of some diseased
condition like crohn’s disease , hepatic disease, pre existing
gastritis ulceration may occurs.
Bacteria H.pylori releases a toxin that destructs or damage
the gastric and duodenal mucosa , reducing the epithelium’s
resistance to acid and causing gastritis and ulcer disease.
7. SIGN AND SYMPTOMS
Vomiting
Bloating
Nausea
Dark blood in stool
Indigestion
Upper abdominal pain
Loss of appetite
8. COMPLICATION
Hemorrhage:- Blood vessels is damaged as ulcer erodes the
muscles of stomach or duodenal wall.
Perforation:- Bacteria and partially digested fool spill into
peritoneum = peritonitis.
Obstruction:- Swelling and scarring can cause obstruction of
food leaving stomach = repeated vomiting.
9. DIAGNOSIS
Endoscopy:- It is the most accurate diagnostic test for peptic
ulcer disease. It involves inserting a small lighted tube
through the throat and into the stomach to look for
abnormalities.
Urea breath test
Radiology
10. PLAN OF TREATMENT
Non pharmacological:- Dietary modification and nutritional supplements,
avoid smoking, tabaco and alcohol, cessation of NSAIDS.
Pharmacological:-
Antibiotics
Antisecretory agents
Antacid
Acid suppressors
Proton pump inhibitor:- Omeprazole, Pantoprazole.
Surgery :- Remove of entire ulcer